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Sensory nerves with endings in the airway mucosa mediate respiratory protective reflexes such as coughing, sneezing, mucus secretion, and bronchoconstriction, which are common symptoms of airway disease. Studies in experimental animals suggest that these reflexes have unique afferent pathways, though these have been difficult to identify in man. One pharmacological tool that is increasingly used in studies of neural reflexes is capsaicin, the pungent agent of hot peppers. Capsaicin seems to excite rather selectively a population of tachykinin peptide containing, chemosensitive afferent nerves.' 2 In rodent airways capsaicin produces severe bronchoconstriction and a pronounced inflammatory response, which seems to be mediated by substance P, neurokinin A, and possibly other tachykinin peptides. 36 Tachykinins contract human bronchi in vitro78 and produce bronchoconstriction when inhaled by asthmatic subjects.9 The density of substance P immunoreactive nerves'0 and expression of the neurokinin, receptor gene" have been reported to be increased in the asthmatic lung. Consequently neuropeptide release, via an axon reflex, has been proposed to be particularly important in the pathology of asthma.'2 The proinflammatory effects so apparent in rodents, however, cannot be reproduced even when high doses of capsaicin are repeatedly inhaled by normal or asthmatic subjects6 and capsaicin sensitive nerves seem unlikely therefore to have a major role in asthma. Instead, experimental and clinical data indicate that their most important function in the human respiratory tract is to mediate protective reflexes. The hypothesis now is that hyperreactivity in these afferent nerves-that is, sensory hyperresponsiveness-contributes to respiratory symptoms in patients with chronic non-productive cough and nonallergic chronic rhinitis.
genes.'5 These tachykinins, and calcitonin gene related peptide, are present in a population of non-myelinated capsaicin sensitive afferent nerves. Neurokinin A is 10 times more potent than 7'horax 1993;48:396-400 substance P in vitro, which may explain why airways obstruction was induced when a large dose was inhaled by asthmatic subjects.9 The bronchoconstriction was inhibited partly by nedocromil sodium and partly by an antimuscarinic agent, indicating that neurokinin A did not act directly on the smooth muscle.28 29 In healthy and asthmatic subjects inhaled capsaicin caused only transient bronchoconstriction (for under a minute) which depends on a parasympathetic cholinergic reflex.'0 Endogenous tachykinins, if released, are therefore unlikely to have any noticeable effects on airway tone in vivo.
It has been speculated that the shedding of epithelium that occurs in severe asthma and upper respiratory tract viral infections reduces airway neutral endopeptidase activity, which is present in the bronchial mucosa and is the major proteolytic enzyme for tachykinins.'6
Consequently the "braking" mechanism would be absent in asthmatic subjects and endogenous tachykinins would be able to exert their proinflammatory effects uninhibited. Thiorphan, a neutral endopeptidase inhibitor, would thus be expected to increase basal tone (by potentiating the effect of endogenous tachykinins) and augment the effects of inhaled peptides in healthy subjects. In asthmatic subjects on the other hand no effect would be expected if neutral endopeptidase is absent.
Inhaled thiorphan, however, was found to have no effect on basal tone but to potentiate inhaled neurokinin A to the same degree in healthy and asthmatic subjects.'132 Nichol and coworkers33 studied the neutral endopeptidase inhibitor acetorphan on reflex bronchoconstriction induced by inhaled metabisulphite in asthmatic subjects. Metabisulphate acts partly via a non-cholinergic mechanism, but its effect was not altered by acetorphan (though weal and flare induced by substance P were significantly potentiated in the same subjects).33 These experiments were conducted in subjects with mild asthma, and if shedding of epithelium is proportional to the severity of the disease, the effect could be more pronounced in severe asthma. The present data support the view that endogenous tachykinins are not important for regulation of bronchial tone in human airways in vivo. Clinical studies with the recently developed potent non-peptide neurokinin receptor antagonists,3435 however, will provide further information on the role of tachykinin peptides in man.
The effects of local application of tachykinins and capsaicin on nasal air flow, leakage of plasma proteins, and secretion have been examined in the human nose. The nasal mucosa is readily accessible and, for example, mediator release and microvascular leakage can be measured non-traumatically. A dose of substance P or calcitonin gene related peptide producing systemic vascular effects (vasodilatation) did not induce secretion or nasal blockage36 37 produce both cough and airway obstruction in asthmatic subjects. Finally, even when a small particle aerosol is inhaled into peripheral airways no bronchoconstriction is produced.46 Taken together, these findings suggest that the afferent function of capsaicin sensitive nerves in the airways is less species specific, and these nerves are likely to subserve protective reflexes in the human respiratory tract.
Sensory hyperresponsiveness
Airway inflammation or chronic irritation with, for example, cigarette smoke may lead to hyperactivity in capsaicin sensitive afferent nerves, as seen in animal experiments. Prolonged exposure (for 14 days) of guinea pigs to cigarette smoke caused an enhanced sensitivity to the tussive effect of citric acid and thus selectively increased the sensitivity and reactivity of capsaicin sensitive nerves mediating cough.47 The airway content of neuropeptides was increased concomitantly,47 but the bronchoconstrictor response was not altered with this treatment. These data indicate that chronic airway irritation may lead to the development of a sensory hyperresponsiveness that is distinct from bronchial hyperresponsiveness. Interestingly, inflammatory stimuli applied to the skin may increase the synthesis of tachykinins in sensory nerves and ganglia,48 49 and in experimental chronic arthritis and inflammatory bowel disease the density of substance P immunoreactive nerves has been reported to be increased.5051
Clinical observations support the existence of a sensory hyperresponsiveness: subjects with cough induced by angiotensin converting enzyme inhibitor,52 or with a chronic cough,53 as well as subjects with a chronic dry cough,54 have an enhanced responsiveness to the tussive effect of inhaled capsaicin without increased bronchoconstrictor responses. Cough is the most common symptom of airway disease, and in chronic obstructive airway disease and in viral infections of the upper respiratory tract part of the excessive coughing is due to a sensory hyperresponsiveness55 (also RW Fuller, personal communication).
It was recently shown that obstruction, rhinorrhoea, and sneezing in patients with nonallergic chronic rhinitis could be significantly reduced after local treatment with capsaicin aerosol that rendered the nerves tachyphylactic.56 57 These clinical findings suggest an important role for tachykinin containing sensory nerves in chronic rhinitis.
Respiratory infections and various forms of sustained irritation of the respiratory tract may lead to neuropeptide synthesis and increased afferent activity with sensory hyperresponsiveness. Sensory hyperresponsiveness may explain some of the symptoms in patients with chronic non-productive cough and non-allergic chronic rhinitis (figure).
Therapeutic implications
The hypothesis that capsaicin sensitive 
